Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com Related Posts Two Pools Project expands with new tenement applications September 11, 2025 Corporate Presentation September 11, 2025 Hydrogen Stocks: 9 Biggest Companies in 2025 September 11, 2025